Testing effectiveness (Phase 2)Study completedNCT02451956
What this trial is testing
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Who this might be right for
Advanced Gastric Cancer
Samsung Medical Center 21